For patients

Information for those taking part in the SIGNET study.


We wish to investigate whether giving deceased organ donors a single dose of the drug Simvastatin, a safe and commonly used drug, is beneficial for transplant recipients.   

Related information

If you have any questions for the researchers or would like further information, please do feel free to get in touch with the research team by emailing